Background: Malignant mesothelioma is an aggressive cancer with no effective treatment
combination of pemetrexed and cisplatin is more effective than cisplatin alone, with differences in response rates of 41.3%, versus 16.3% [4] . However, most of the patients relapsed within a year after starting the treatment. Therefore, new therapeutic approaches are urgently needed for malignant mesothelioma patients.
Vitamin E is one of the most promising lipophilic antioxidants, consisting of eight naturally occurring forms, known as tocopherols (Ts), and tocotrienols (T3s). Ts carry a saturated phytyl group that is derived from homogentisic acid and phytyl pyrophosphate, whereas T3s are thought to arise from the condensation of homogentisic acid and geranylgeranyl pyrophosphate [5] . Ts and T3s can be subdivided into four isomers ( and δ) relating to the numbers and the position of the methyl groups on their chromanol ring.
The major source of vitamin E is plant-derived oils. T3s are the major vitamin E component of palm oil. Significant amounts are also found in barley, oats, and rice bran [6, 7] . Since T3s differ from Ts by the presence of three trans double bonds in the hydrocarbon tail, T3s are thought to assume a unique conformation. Therefore, members of the natural vitamin E family possess overlapping and unique functional properties that could be due to their structural difference. Among these, T3s, but not Ts, have been linked to additional beneficial therapeutic properties, such as lowering serum cholesterol levels when administered in the diet of hypercholesterolemic humans [8] . Moreover, recent studies also revealed their beneficial biological properties, such as anti-angiogenesis, and anticancer activities [9] . Therefore, T3s are one of the attractive groups, not only as a functional food constituent but also as a clinical therapeutic agent. Especially, -T3 is the most potent anti-cancer isoforms of T3 isforms, so this isform is as promising as a clinical therapeutic agent.
Cyclodextrins (CDs) are polysaccharides built from six to eight (α=6, β=7, =8) D-glucose units. The -CD, -CD and -CD are widely used natural CDs. The D-glucose units are covalently linked at the carbon atoms C1 and C4 to form a macrocycle [10, 11] . CDs can generally form inclusion complexes with a number of lipophilic substances, and thus have been used for improving their water solubility, stability, diffusibility, and bioavailability [12, 13] . Previous studies have shown that the bioavailability of coenzyme Q10 was improved by CD inclusion [14] . Among the three natural CDs, -CD shows the highest water solubility and is the only form digested in the intestinal tract. Therefore, much attention has recently been given to the usage of -CD as a -host‖ molecule of the inclusion complex in oral bioavailability experiments and as a promising nutrition delivery system. The aim of this study was to examine the effect of -T3 inclusion with -CD on its bioavailability. Further, we evaluated anti-mesothelioma activity of this inclusion. A T3-rich fraction (TRF) was prepared by extraction from rice bran, which is a readily available and abundant source of γ-T3.
METHODS:
A 
RESULTS:
We investigated the effect of -T3 inclusion with -CD on tumor development. Eight days 
DISCUSSION:
In our previous study [16] , we compared the bioavailability of -T3 when given as a TRF inclusion complex with CD with that administered as a free form dissolved in corn oil. The
Cmax and AUC values for plasma -T3 levels were markedly greater in mice administered TRF/CD orally than those given TRF alone. Moreover, TRF/CD-administered mice tended to be more resistant against the lethal effects of LPS-induced endotoxin shock than those given With respect to anti-cancer mechanism of -T3, several types of targets have been reported [9] . Of the determined target molecules, c-Src is one of the promising target molecules in mesothelioma [17] . The expression of activated c-Src correlates with advanced-stage and metastasis of mesothelioma [18] . It suggests the involvement of c-Src in driving oncogenesis. Furthermore, inhibition of Src expression and activation in mesothelioma leads to apoptosis, cell cycle arrest, and suppression of invasion [19] . It has been reported that T3 inhibited c-Src kinase activity or regulated one or more events upstream of c-Src kinase activation in brain tissues [20] . Additionally, we observed that the expression of VEGF, a main molecule located in the downstream of c-Src signaling [21] transcription factor for VEGF [22] ; (2) the inhibition of c-Src leads to the inactivation of Stat3 as a transcription factor [22] ; (3) consecutive activation of Stat3 has been observed in human mesothelioma cells [23] ; (4) a specific inhibitor towards Stat3 effectively has negative growth control against mesothelioma cells [18] . These reports suggest that Stat3 is a main molecule in c-Src signaling to be necessary for anti-mesothelioma effect of -T3. Overall, it seems to be possible that c-Src/Stat3 signaling contribute to -T3-dependent negative growth control of mesothelioma cells in vivo.
CONCLUSION:
-T3 inclusion complex with CD is a promising procedure to improve human mesothelioma treatment.
